Ocean Biomedical Inc. (OCEA)
0.04
-0.00 (-9.09%)
At close: Apr 16, 2025, 3:59 PM
0.04
0.63%
After-hours: Apr 16, 2025, 07:41 PM EDT
-9.09% (1D)
| Bid | 0.04 |
| Market Cap | 7.04M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -3.3M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | -0.03 |
| Analyst | n/a |
| Ask | 0.04 |
| Volume | 6,505,643 |
| Avg. Volume (20D) | 56,003,726 |
| Open | 0.04 |
| Previous Close | 0.04 |
| Day's Range | 0.04 - 0.04 |
| 52-Week Range | 0.04 - 2.09 |
| Beta | 1.63 |
About OCEA
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, infectious diseases, and inflammation. The company is developing mono-specific and bi-specific humanized monoclonal antibodies (mAb) product candidates targeting Chi3l1 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatm...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 8, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol OCEA
Website http://www.oceanbiomedical.com
2 months ago
-26.33%
Ocean Biomedical shares are trading higher after t...
Unlock content with
Pro Subscription
